治疗性超声预处理联合普通球囊血管成形术治疗严重肢体缺血膝下病变的6个月血管造影与临床结局:前瞻性单中心初步研究
这项前瞻性单中心初步研究纳入12例严重肢体缺血患者(共19处膝下病变,11处严重钙化),先用Kapani超声系统进行低频高强度超声能量输送,再行普通球囊扩张。技术成功率达全部病变,6个月血管造影原发通畅率为18/19(95%),无死亡、靶病变血运重建或截肢,12例患者溃疡全部愈合。提示该联合疗法对钙化膝下病变安全且6个月结局良好,需更大样本随机研究证实。
要点
- 低频高强度超声预处理后普通球囊扩张治疗膝下钙化病变技术成功率高,无并发症或支架植入。
- 6个月原发通畅率达95%(18/19病变),无死亡、靶病变血运重建或截肢。
- 12例严重肢体缺血患者6个月时溃疡全部愈合。
核心结论
- 低频高强度超声能量输送后联合普通球囊血管成形术是治疗膝下动脉粥样硬化病变的安全方法。
- 6个月血管造影结果提示该联合疗法对钙化膝下病变的严重肢体缺血患者具有潜力。
研究设计与样本
- 前瞻性、非随机、单中心初步研究,2017年1月至11月纳入12例严重肢体缺血患者(平均年龄72.2±5.3岁,8例男性;Rutherford 5级9例、6级3例)。
- 共19处靶病变,其中11处为严重钙化;患者先接受Kapani超声系统治疗,再行普通球囊扩张。
主要发现
- 技术成功(残余狭窄<30%)在所有病变中实现,无并发症或支架植入。
- 超声能量输送时间平均185.2±67.3秒,随后低压扩张平均6.1±1.9 atm。
- 6个月血管造影原发通畅率为18/19(95%)。
- 随访期间无死亡、靶病变血运重建或截肢报告。
- 6个月时全部12例患者溃疡完全愈合。
关键数值与推荐
- 主要安全终点包括30天死亡、主要靶肢体截肢和靶血管急性闭塞。
- 主要疗效结局为6个月原发通畅,定义为无临床驱动的靶病变血运重建且无血管造影定义的再狭窄(管腔减少>50%)。
临床怎么用
- 对于严重肢体缺血的钙化膝下病变,可考虑采用低频高强度超声预处理后普通球囊扩张,以避免支架植入。
- 该方案在初步研究中显示6个月原发通畅率高且无严重不良事件,但需更大规模随机研究验证。
局限性
- 样本量小(12例患者、19处病变),为非随机单中心初步研究。
- 需进一步开展更大样本的随机队列研究以确认阳性临床结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the safety and efficacy of low-frequency, high-intensity ultrasound energy delivered via a new dedicated ultrasound catheter followed by conventional balloon angioplasty to treat calcified infrapopliteal lesions. MATERIALS AND METHODS: A prospective, nonrandomized, single-center pilot study enrolled 12 patients (mean age 72.2±5.3 years; 8 men) with critical limb ischemia (9 Rutherford category 5 and 3 category 6) between January and November 2017. Of the 19 target lesions, 11 had severe calcification. Patients were treated with the Kapani ultrasound system before conventional balloon dilation. Primary safety endpoints included 30-day death, major target limb amputation, and target vessel acute occlusion. The main efficacy outcome was primary patency at 6 months, defined as freedom from both clinically-driven target lesion revascularization (TLR) and angiographically-defined restenosis (>50% lumen reduction). RESULTS: Technical success (<30% residual stenosis) was achieved in all lesions without complications or stent implantation. Ultrasound energy was delivered over a mean 185.2±67.3 seconds followed by low-pressure dilation (mean 6.1±1.9 atm). Angiography confirmed primary patency at 6 months in 18 (95%) of 19 lesions. No death, TLR, or amputation was reported in follow-up. Complete ulcer healing was observed in all 12 patients at 6 months. CONCLUSION: This pilot trial with a small number of patients suggests that low-frequency, high-intensity ultrasound energy delivery followed by plain balloon angioplasty is a safe approach to treat infrapopliteal atherosclerotic lesions. Angiographically-documented results at 6 months indicate a potential for this combined therapy in the treatment of CLI patients with calcified BTK lesions. Further studies on a larger randomized cohort are needed to confirm these positive clinical outcomes.
引用
- Del Giudice C, Gandini R. Six-Month Angiographic and Clinical Outcomes of Therapeutic Ultrasound Pretreatment Associated With Plain Balloon Angioplasty for Below-the-Knee Lesions in Patients With Critical Limb Ischemia: A Prospective, Single-Center Pilot Study. J Endovasc Ther. 2019. PMID: 30741077. doi:10.1177/1526602819829904
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。